A large number of studies have proved that the combination of breast cancer cell CXCR4 and its ligand CXCL12 can promote the proliferation of primary tumor and distant metastasis of liver, lung, and brain, which will aggravate the patient's condition and increase the difficulty of treatment [23]. Here, CXCL12 is linked to breast carcinoma.